Product nameAnti-CD3 antibody [UCHT1] (Allophycocyanin/Cy7 ®)
See all CD3 primary antibodies
DescriptionMouse monoclonal [UCHT1] to CD3 (Allophycocyanin/Cy7 ®)
ConjugationAllophycocyanin/Cy7 ®. Ex: 650nm, Em: 774nm
SpecificitySpecific for the epsilon chain of the CD3/T cell antigen receptor complex.
Tested applicationsSuitable for: Flow Cyt, Cellular Activation, IHC-Fr, IPmore details
Species reactivityReacts with: Human
The details of the immunogen for this antibody are not available.
General notesThis product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5,268,486 and related patents. Cy and CyDye are trademarks of GE Healthcare Limited.
Storage instructionsShipped at 4°C. Store at +4°C.
Storage bufferpH: 7.2
Preservative: 0.09% Sodium azide
Constituents: 0.14% Monobasic dihydrogen sodium phosphate, 0.87% Sodium chloride, 0.1% Gelatin
Also contains a stabilizing agent.
Concentration information loading...
- Anti-CD3 antibody [UCHT1], prediluted (PerCP) (ab106215)
- Anti-CD3 antibody [UCHT1] - Low endotoxin, Azide free (ab119110)
- Anti-CD3 antibody [UCHT1], prediluted (PE/Cy5®) (ab157300)
- Anti-CD3 antibody [UCHT1], prediluted (PerCP/Cy5.5®) (ab157317)
- Anti-CD3 antibody [UCHT1] (Biotin) (ab191112)
- Anti-CD3 antibody [UCHT1] (Allophycocyanin) (ab239287)
- Anti-CD3 antibody [UCHT1] (redFluor™ 710) (ab241935)
- Anti-CD3 antibody [UCHT1] (violetFluor™ 450) (ab241941)
- Anti-CD3 antibody [UCHT1] (FITC) (ab34275)
- Anti-CD3 antibody [UCHT1] (PE/Cy7 ®) (ab81992)
Our Abpromise guarantee covers the use of ab82013 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Flow Cyt||Use at an assay dependent concentration.|
|Cellular Activation||Use at an assay dependent concentration.|
|IHC-Fr||Use at an assay dependent concentration.|
|IP||Use at an assay dependent concentration.|
FunctionThe CD3 complex mediates signal transduction.
Involvement in diseaseDefects in CD3D are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)/B(+)/NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Sequence similaritiesContains 1 ITAM domain.
- Information by UniProt
- 4930549J05Rik antibody
- A430104F18Rik antibody
- AW552088 antibody
ab82013 has not yet been referenced specifically in any publications.